The Channel-Forming Sym1 Protein Is Transported by the TIM23 Complex in a Presequence-Independent Manner T ransfer of metabolites or polypeptides across the inner mitochondrial membrane relies on dedicated and highly selective transporters. Mitochondria import the vast majority of proteins from the cytoplasm. While most of these proteins use aminoterminal-targeting signals (presequences) for transport, which direct the proteins across the outer and inner membranes of the mitochondria, many multispanning inner membrane proteins, such as the metabolite carriers and channel-forming subunits of the inner membrane protein translocases, utilize internal targeting signals. The transport of multispanning proteins into the inner membrane has been studied most for metabolite carriers, and five distinct transport stages have been identified (4, 11, 40, 46, 49) . Initially, carrier proteins associate with chaperones in the cytosol that prevent aggregation of the hydrophobic molecules (stage I) (81, 83) . Tom70 is the major receptor for internal targeting signals in the translocase of the outer membrane (TOM) complex (53, 61) . In addition to the signal elements of the precursor, Tom70 also binds precursor-associated chaperones (stage II) (79) . ATP hydrolysis by the substrate-carrying chaperones releases the carrier molecules for transfer across the TOM complex toward the intermembrane space. The carrier molecule traverses the Tom40 channel of the TOM complex in a hairpin-like conformation and associates with the small translocase of mitochondrial inner membrane (TIM) chaperone complex in the intermembrane space (stage III) (6, 12, 27, 34, 59, 67, 75) . In in vitro import analyses, this stage can be stabilized when the membrane potential across the inner membrane is dissipated by ionophores. Inner membrane insertion of carriers is mediated by the carrier translocase (TIM22 complex). The small TIM complex delivers the carriers from the TOM to the TIM22 complex, which derives energy from the membrane potential to drive membrane insertion of the precursor (stage IV) (17, 31, 50, 58) . Eventually, the carriers assemble into functional oligomers (stage V) (50) . In contrast to metabolite carriers and channels of the inner mitochondrial membrane, a group of multispanning membrane proteins, such as the ABC transporters and the insertase OxaI, contain N-terminal presequences (2, 16, 20) . The insertion of these proteins into the lipid phase requires the presequence translocase (TIM23 complex), which initially recognizes the precursor through an interaction between the presequence and the receptor Tim50 (35, 56) . Recognition of the presequence is thought to activate the translocase and thus to initiate membrane translocation (66) .
MPV17 (Sym1 in Saccharomyces cerevisiae) belongs to a family of proteins conserved from hydrogenosomes in the anaerobic ciliate Nyctotherus ovalis to the mitochondria of yeast and mammals (3) . All family members are multispanning membrane proteins with four predicted transmembrane spans. MPV17 was first identified in a mouse strain generated by random retrovirus integration, which was affected by nephrotic syndrome (72) . Defects in human MPV17 cause a dramatic reduction of mitochondrial DNA, described as the hepatocerebral form of the inherited autosomal mitochondrial DNA depletion syndrome (MDDS) (64) . As a result of MPV17 loss of function, respiration and other mitochondrial activities are dramatically reduced in tissues (69) . Patients with MDDS display liver failure, hypoglycemia, growth retardation, and neuronal disorders within the first year of their life. The molecular functions of MPV17 and its yeast homolog Sym1 have remained enigmatic.
In S. cerevisiae, two proteins show similarity to MPV17: Sym1, residing in the inner mitochondrial membrane (similar to MPV17), and the product of the uncharacterized open reading frame YOR292c, which has been localized to the vacuole (21) . Complementation of the yeast SYM1 deletion by expression of the human MPV17 gene defines these two proteins as functional orthologs and has established Sym1 as a model for MPV17 function (63) . The observed reduction of steady-state protein levels of mutated MPV17 in patient cells has raised questions regarding the stability of the protein or, alternatively, could indicate mistargeting within patient cells (63) . Therefore, we studied the import and assembly of Sym1 in yeast mitochondria. Surprisingly, Sym1 does not carry a cleavable presequence, as N-terminal truncations do not affect translocation and integration into the inner membrane. We found that purified Sym1 forms an aqueous channel upon reconstitution in black lipid membranes. Based on this observation, we speculated that, similar to the Tim23 and Tim22 channels, Sym1 could follow the carrier pathway into the mitochondria. Although our analyses revealed transport intermediates, which strongly resembled those of carrier proteins, Sym1 assembled independently of the carrier pathway. Surprisingly, we found that Sym1 is transported and integrated into the inner membrane in a presequence-independent manner via the presequence translocase (TIM23). Thus, our analysis identified a novel role of the presequence translocase complex in the insertion of a protein with internal signals into the inner membrane.
MATERIALS AND METHODS
Yeast strains, human cell lines, and isolation of mitochondria. Saccharomyces cerevisiae sym1⌬ and SYM1 ZZ strains used in this study were derived from YPH499 by chromosomal integration (22, 25 ⌬PBD-HA (aa 1 to 365) under the control of the MET25 promoter, have been described previously (56) . The tom22
His , tim5-1, tim10-2, tim54-11, and tim12-4 strains and the strain expressing TIM23 under the control of the GAL1 promoter have been described previously (5, 17, 38, 56, 67, 71) . For in vivo studies on the membrane integration of Sym1 ZZ and Sym1
ZZ lacking the N terminus (amino acids [aa] 1 to 16), the constitutive ADH promoter was integrated either directly before or 16 codons downstream of the SYM1 start codon in the SYM1 ZZ yeast strain. Yeast cultures were grown at 24°C or 30°C, unless otherwise indicated, in rich medium (1% yeast extract, 2% peptone, and 2% dextrose or 3% glycerol). Yeast mitochondria were isolated as described previously (37) . Human mitochondria were isolated from HEK293T cells (32) and cultured in Dulbecco's modified Eagle medium (Gibco; Invitrogen) supplemented with 10% fetal bovine serum (Biochrom) at 37°C in a 5% CO 2 atmosphere.
In vitro import and assembly into isolated mitochondria. For synthesis of 35 S-labeled precursor proteins, the respective open reading frames were cloned downstream of the SP6 promoter in pGEM4Z (Promega) or pCR-Blunt2-TOPO (Invitrogen). Plasmids were used to synthesize 35 S-labeled precursor proteins by coupled in vitro transcriptiontranslation (TNT quick coupled transcription-translation system; Promega). Alternatively, the open reading frames were amplified from plasmid DNA by PCR, transcribed and purified (mMessage mMachine SP6 system and MEGAclear kit; Ambion), and subsequently used for in vitro translation (Flexi rabbit reticulocyte lysate system; Promega).
In vitro imports of radiolabeled precursor proteins into isolated yeast or human mitochondria were performed as described previously (32, 74) . After import, samples were analyzed by SDS-PAGE or blue-native PAGE (BN-PAGE), and 35 S-labeled proteins were detected by digital autoradiography and quantified using ImageQuant TL software (GE Healthcare).
Antibody shift and depletion assays. An in-gel antibody shift assay of protein complexes was performed by the addition of 2% (vol/vol) antiserum after in vitro import. After incubation for 30 min at 4°C, mitochondria were sedimented by centrifugation, and samples were processed for BN-PAGE. For complex depletion analysis, [ 35 S]Sym1 was imported in vitro into tom22
His mitochondria. Subsequently, mitochondria were solubilized for 30 min in 1% digitonin, 20 mM Tris-HCl (pH 7.4), 0.1 mM EDTA, 50 mM NaCl, 10% (wt/vol) glycerol, and 1 mM phenylmethylsulfonyl fluoride (PMSF). We then added 5% (vol/vol) (bed volume) Ninitrilotriacetic acid (NTA) agarose (Qiagen), and after incubation for 30 min at 4°C, beads were sedimented and the supernatant was analyzed by BN-PAGE and digital autoradiography.
Triplex isolation of Sym1 from yeast mitochondria. Sym1 was purified from Sym1
ZZ mitochondria by double-affinity chromatography followed by tobacco etch virus (TEV) protease cleavage (30) . In brief, mitochondria were resuspended to a protein concentration of 10 mg/ml in buffer A (1% SDS, 10% [wt/vol] glycerol, 100 mM NaCl, 10 mM imidazole, 1 mM PMSF, 50 mM NaH 2 PO 4 ). Proteins were denatured by incubation for 15 min at 25°C. Subsequently, proteins were 20ϫ diluted with buffer B (0.2% Triton X-100, 10% [wt/vol] glycerol, 100 mM NaCl, 10 mM imidazole, 1 mM PMSF, 50 mM NaH 2 PO 4 ) and incubated for 30 min at 4°C. After a clarifying spin (15 min, 4°C, 20,000 ϫ g), the supernatant was incubated with Ni-NTA agarose beads. Beads were washed with buffer C (0.1% Triton X-100, 10% [wt/vol] glycerol, 100 mM NaCl, 10 mM imidazole, 1 mM PMSF, 50 mM NaH 2 PO 4 ), and bound proteins were eluted using the same buffer supplemented with 300 mM imidazole. Subsequently, imidazole was diluted using buffer C, and samples were incubated with IgG-Sepharose beads. Beads were washed extensively with buffer C, and bound protein was released from the Sepharose by TEV protease cleavage. His-tagged TEV protease was removed by incubation with Ni-NTA agarose beads.
Electrophysiological characterization of Sym1 in planar lipid bilayers. Planar lipid bilayers were formed using the painting technique. In brief, a lipid solution of purified L-␣-phosphatidylcholine (60 mg/ml, type IV-S) (Sigma) in decan (purity Ͼ 99%) (Sigma) was applied to a hole in the polytetrafluoroethylene (PTFE) membrane, which separates two chambers. After successful bilayer formation, which was monitored optically, Sym1 was inserted into the membrane by osmotic fusion of proteoliposomes with the bilayer under asymmetrical buffer conditions (250 mM KCl and 10 mM MOPS [morpholinepropanesulfonic acid]-Tris [pH 7 .0] in the cis chamber and 20 mM KCl and 10 mM MOPS-Tris [pH 7.0] in the trans chamber). Ag/AgCl electrodes were connected to the chambers using 2 M KCl-agar bridges. The membrane potentials refer to the trans compartment, as the electrode of this compartment was directly connected to the headstage of a current amplifier (Axon Gene Clamp 500; Axon Instr.). A self-created analysis software in combination with Origin 6.0 (MicroCal Software Inc.) was used to analyze the current recordings.
Miscellaneous. Standard techniques were used for SDS-PAGE and Western blotting of proteins to polyvinylidene difluoride (PVDF) membranes. Proteins were probed using primary antibodies raised in rabbits and secondary antibodies coupled to horseradish peroxidase (HRP). Signals were detected using an enhanced chemiluminescence (ECL) detection system (GE Healthcare) and X-ray films.
Blue-native PAGE was performed essentially as described previously (9) . Mitochondria were solubilized in 1% digitonin, 20 mM Tris-HCl (pH 7.4), 0.1 mM EDTA, 50 mM NaCl, 10% (wt/vol) glycerol, and 1 mM PMSF for 30 min at 4°C. After a clarifying spin (15 min, 20,000 ϫ g, 4°C) and the addition of 10ϫ loading dye (5% Coomassie brilliant blue G-250, 500 mM ε-amino n-caproic acid, 100 mM Bis-Tris [pH 7.0]), the supernatant was separated on a 6 to 16% polyacrylamide gradient gel. For 2-dimensional BN-PAGE/SDS-PAGE, a lane was cut out after the BN-PAGE run and mounted on top of an SDS-PAGE gel.
Digital autoradiography of radiolabeled proteins was performed by exposition of dried SDS or BN gels to storage phosphor screens (GE Healthcare). Signals were detected using the Storm 820 scanner (Storm imaging system; GE Healthcare).
For submitochondrial protein localization, mitochondria were osmotically stabilized in SEM buffer (250 mM sucrose, 1 mM EDTA, 10 mM MOPS [pH 7.2]) or the outer mitochondrial membrane was disrupted by osmotic swelling in EM buffer (1 mM EDTA, 10 mM MOPS [pH 7.2]) prior to treatment with the indicated concentrations of proteinase K for 10 min on ice. Subsequently, proteinase K was inactivated, and samples were analyzed by SDS-PAGE and Western blotting. For carbonate extraction of mitochondrial membranes, isolated mitochondria were incubated in 100 mM Na 2 CO 3 at pH 10.8 or pH 11.5 for 20 min on ice. Extracted membranes were separated by ultracentrifugation at 100,000 ϫ g for 30 min. Proteins from total samples and supernatant and pellet fractions were precipitated in 13% trichloroacetic acid (TCA) and washed with ice-cold acetone before separation by SDS-PAGE and Western blotting.
RESULTS
Purification and biochemical characterization of Sym1. The yeast Sym1 protein shares high sequence similarities with its human and mouse orthologues (Fig. 1A) . Both human MPV17 and yeast Sym1 have been localized to the inner mitochondrial membrane and display similar membrane topologies, with four predicted transmembrane spans (63, 65, 77) . For biochemical characterization of Sym1, we generated a yeast strain (SYM1 ZZ ) expressing Sym1 from its own promoter, which was fused to two repeats of the IgG-binding domain of protein A (the Z domain) followed by a polyhistidine tag at its C terminus. A TEV cleavage site between Sym1 and the first Z domain allowed specific cleavage of the tag by TEV protease treatment (Fig. 1B) . To assess the expression of SYM1 ZZ , we isolated mitochondria and subjected them to Western blot analysis. Detection of the ZZ tag with peroxidase antiperoxidase (PAP) antibody (HRP-anti-HRP) revealed a protein of the predicted size, indicating stable expression of SYM1 ZZ in yeast (Fig. 1C , lanes 3 and 4). An antiserum against a C-terminal peptide of Sym1 revealed one predominant signal in wild-type mitochondria which was shifted to a higher molecular mass in mitochondria from SYM1 ZZ yeast (Fig. 1C , lanes 1 and 2). We confirmed the correct localization of Sym1 ZZ within mitochondria by using protease protection assays to compare mitochondria and mitoplasts (generated by rupture of the outer membrane in a hypo-osmotic buffer). In mitochondria and mitoplasts, the outer membrane proteins (e.g., Tom70) were degraded by externally added proteases, whereas matrix proteins, such as Tim44, remained protected in both cases. The intermembrane space domain of Tim23 became accessible to protease treatment only in mitoplasts (Fig. 1D) . We detected Sym1 ZZ with the Sym1 antibody (data not shown) and the PAP antibody ( Fig. 1D ) and observed protease accessibility only after removal of the outer membrane. Neither of the antibodies detected protease-stable fragments of Sym1, indicating that the C terminus was exposed to the intermembrane space (IMS). We concluded that Sym1 ZZ , like endogenous Sym1, was integrated in the inner membrane with an N out /C out orientation (65) .
Sym1-related Pxmp2 is a peroxisomal membrane protein in mice which was suggested to form a largely unregulated diffusion pore (52) . To investigate if Sym1 forms a channel in the mitochondrial inner membrane, we established a protocol for purification and reconstitution of Sym1 ZZ into lipid bilayers (Fig. 1E ). We isolated mitochondria from Sym1 ZZ yeast cells and solubilized mitochondrial membranes under denaturing conditions. The His tag on Sym1
ZZ was used to isolate Sym1 by Ni affinity chromatography. Eluted proteins were diluted to allow refolding of the ZZ tag. Sym1
ZZ was recovered in a second purification step using IgG affinity chromatography followed by TEV protease cleavage of the fusion protein (see above). The purification procedure was monitored by Western blot analysis (Fig. 1F) , and the purity of isolated Sym1 was confirmed by SDS-PAGE and Coomassie brilliant blue staining (Fig. 1G ). Sym1 was inserted into small unilamellar vesicles by detergent-mediated reconstitution (66) . For the electrophysiological measurements, we fused the Sym1-containing proteoliposomes with planar lipid bilayers. A mock purification sample from wild-type mitochondria served as a control.
Sym1 forms a channel in lipid membranes. Analysis of singlechannel recordings of bilayers containing Sym1 ( Fig. 2A ) in 250 mM KCl showed rectifying conductivity with main conductance states (G) of ϳ510 pS when positive membrane potentials were applied and ϳ450 pS with negative membrane potentials applied (Fig. 2B) . No signs of ion channel activity were detected in the mock control. The channel exhibited a reversal potential (U rev ) equaling ϳ48 mV (cis, 250 mM KCl; trans, 20 mM KCl), from which, according to the Goldman-Hodgkin-Katz (GHK) approach, a preference for cations with a permeability ratio of P K ϩ / P Cl Ϫ equal to 14/1 can be calculated (Fig. 2C) . Interestingly, a voltage-dependent closure of the channel was detected. At membrane potentials above Ϯ150 mV, the open probability was reduced by 50% (Fig. 2D) . To unambiguously show that the measured channel activity was attributable to Sym1, we performed experiments with antibodies raised against Sym1. The addition of antibodies led to a decrease of the channel conductivity (Fig. 2E) . A significant change in the pattern of gating events was observed before and after the addition of antibody. This change was manifested in a shift of the amplitude and frequency of conductance states as calculated from single gating events (Fig. 2F) . In summary, Sym1 constitutes a rectifying high-conductance cation-selective ion channel in the inner mitochondrial membrane which is voltage regulated. Our results suggest that this channel closes at the physiological membrane potential of the inner mitochondrial membrane. This voltage sensitivity would prevent ion leakage across the inner membrane.
Internal targeting signals direct the import of Sym1 into mitochondria. The architectures of the transmembrane helices of Sym1 and MPV17 are highly conserved and share topological similarities with two other channel proteins of the inner mitochondrial membrane, Tim23 and Tim22. Based on the characteristic topology of their four transmembrane spans in an N out /C out orientation, Tim22 and Tim23 and the chloroplast Oep16 have been described as founding members of the preprotein and amino acid transporter (PRAT) protein family (48) . Sym1 not only shares the same topology as Tim23, Tim22, and Oep16 (Fig. 3A) but also displays similar channel activity (28, 36, 47) . Tim22 and Tim23 utilize internal targeting signals for import into mitochondria and are transported along the carrier pathway. In contrast, previous studies have suggested that a presequence at the N terminus of MPV17 is responsible for its import into mitochondria (63) , in-dicating a transport mechanism via the TIM23 complex. Indeed, with MitoProtII, a presequence was predicted for MPV17 and Sym1 (human MPV17, 86.0%; mouse MPV17, 85.4%; Sym1, 82.8%). As only a limited number of polytopic TIM23 substrates are known, we studied the import pathway of MPV17 and Sym1 directly.
MPV17 was synthesized in an in vitro transcription-translation system in the presence of radiolabeled [ 35 S]methionine and imported into energized human mitochondria. MPV17 was efficiently imported into mitochondria and protected against protease treatment (Fig. 3B) . Interestingly, the MPV17 precursor was not processed to a faster-migrating form during import. In con- ZZ strain were subjected to SDS-PAGE and Western blotting using antibodies against Sym1 and PAP (HRP-anti-HRP). (D) Mitochondria were left untreated or subjected to swelling in hypo-osmotic buffer, treated with the indicated amounts of protease, and subjected to SDS-PAGE and Western blotting. Sym1 ZZ was detected using PAP. Prot. K, proteinase K. (E) Flow diagram of the isolation strategy for Sym1 ZZ . (F) Total (5%), unbound (UB) (5%), and eluate (E) (E Ni , 5%; E IgG , 100%) fractions of Ni-NTA affinity and IgG affinity chromatography were separated by SDS-PAGE and subjected to Western blot analyses using the Sym1 antibody. (G) Coomassie brilliant blue-stained SDS-PAGE gel of the IgG chromatography eluate.
trast, the presequence-containing precursor of SURF1 was processed to a mature form in the presence of a membrane potential (⌬) (51, 78) . In the absence of a ⌬, only a partial reduction of MPV17 import was observed, suggesting that a fraction of MPV17 was transported to a protease-protected location within mitochondria, independent of the membrane potential. This import behavior was reminiscent of carrier pathway substrates (45, 53, 82) . This surprising finding led us to investigate the import of Sym1 into yeast mitochondria. We synthesized the Sym1 precursor in a coupled in vitro transcription-translation system. Sym1 was efficiently imported into isolated yeast mitochondria (Fig. 3C) . Similar to MPV17, Sym1 was not processed during import, while in a control experiment, the precursor of F 1 -ATPase ␤ subunit (F 1 ␤) was imported and processed in a ⌬-dependent manner. In contrast to F 1 ␤, for Sym1 in the absence of ⌬, only a fraction was accessible to protease, results similar to those for the MPV17 import. To exclude the possibility that Sym1 displayed intrinsic protease resistance, sonicated mitochondria were protease treated (Fig. 3E, lanes 10 and 11) , resulting in efficient degradation of Sym1. Interestingly, when purified SYM1 mRNA was synthesized in an in vitro translation system, we observed an additional translation product, likely originating from a second start codon in SYM1, which was also imported into mitochondria despite the lack of its N terminus (Fig. 3E) . Thus, both MPV17 and Sym1 showed no processing of the N terminus. To validate this finding, we purified Sym1
ZZ from mitochondria and analyzed the N terminus by Edman sequencing and mass spectrometry. These analyses confirmed that the mature N terminus corresponded to the nonprocessed protein. We therefore asked if the predicted presequence at the N terminus of the protein was required for import, and we generated truncation constructs with increasing N-terminal deletions of Sym1 (Fig. 3D) . Similar to the full-length protein (and the fragment generated from the second start codon), all Sym1⌬N constructs were imported into mitochondria. Like full-length Sym1, a fraction of the truncation constructs were transported to a protease-inaccessible location in a ⌬-independent manner but became accessible to protease by sonication (Fig. 3E) . To ensure that the N terminus of Sym1 was not required for import and membrane integration in vivo, we expressed Sym1 ZZ and Sym1 ZZ lacking the N terminus (aa 1 to 16) in yeast cells. Both proteins were recovered in mitochondria and displayed resistance to carbonate extraction, indicating that they were integral membrane proteins (Fig. 3F) . Taken together, our data show that internal targeting signals are responsible for the import of Sym1 and MPV17 into mitochondria. Moreover, in the absence of a ⌬, the observed import resembled the protease-protected stage III intermediate of carrier transport (45, 53, 80) .
Sym1 assembles into high-molecular-mass complexes in the inner membrane. A common feature of carrier proteins in the inner membrane is their organization into high-molecular-mass complexes, which can be analyzed by BN-PAGE (42, 43) . To assess complex formation, Sym1 ZZ mitochondria were solubilized, and the complexes were analyzed by BN-PAGE and Western blotting. Wild-type and sym1⌬ mitochondria were analyzed as controls. Sym1
ZZ -specific signals were detected at molecular masses of 120 and 220 kDa (Fig. 4A) . We enriched these complexes by native isolation of Sym1-containing complexes by IgG chromatography. Eluates were analyzed by BN-PAGE and stained with Coomassie brilliant blue. Two bands (120 and 220 kDa) were clearly visible and resembled the results of the Western blot analysis (Fig. 4B) . To verify complex formation of endogenous (nontagged) Sym1, we used 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE) (1st dimension, BN-PAGE; 2nd dimension, SDS-PAGE), as the Sym1 antibody did not recognize Sym1 in complexes on native gels. We detected 120-kDa and 220-kDa complexes of endogenous Sym1 (Fig. 4C ). According to their molecular masses, the two complexes were termed Sym1 c120 and Sym1 c220 . Inner membrane complex oligomers, such as respiratory chain supercomplexes and ADP-ATP carrier (AAC) oligomers, have been found to be stabilized by the inner membrane lipid environment. Such complexes are best maintained for biochemical analyses in the detergent digitonin, but they dissociate under harsher conditions (55, 76) . Thus, we compared the solubilization behavior of Sym1 to AAC and respiratory chain supercomplexes in digitonin with dodecyl maltoside. Similar to AAC and respiratory chain supercomplexes, Sym1 complexes were shifted to a lower molecular-mass range (Fig. 4D) when dodecyl maltoside was used as the detergent.
The visualization of complexes by BN-PAGE in combination with the import of Sym1 allowed us to study the kinetics of assembly. We therefore imported Sym1 into isolated mitochondria and analyzed the complexes after solubilization by BN-PAGE. Sym1 formed complexes of different molecular masses in a time-and ⌬-dependent manner (Fig. 4E) . After short import times (0.5 to 2 min), a signal in the low-molecular-mass range transiently peaked and subsequently decreased (Fig. 4E, lanes 2 and 3) . The small molecular size and comigration with in vitro-synthesized Sym1 (Fig. 4E, lane 1) and its transient appearance led us to conclude that it represented monomeric Sym1 (Sym1 m ). With a slight delay, a second complex of 450 kDa peaked after 2 min (Fig. 4E,  lane 3) . Based on its size, we speculated that this form could represent an assembly intermediate in the TOM complex (Sym1 TOM ). The final products of the import reactions were the two mature complexes, Sym1 c120 and Sym1 c220 . These two complexes formed last and coincidentally with the decrease of the intermediate products. The assemblies of both complexes were dependent on the ⌬. Only in the absence of ⌬ was a proteaseinaccessible complex of approximately 100 kDa formed in addition to the monomeric Sym1. We termed this 100-kDa complex Sym1 IMS because it was resistant to protease treatment and had thus passed through the outer membrane, while at the same time, due to the lack of ⌬, it was not inserted into the membrane. The formation of protease-resistant complexes in the absence of a ⌬ resembled the well-characterized stage III intermediates in the import pathway of carrier proteins. These intermediates are released from the TOM complex on BN-PAGE and thus run in the low-molecular-mass range (10, 34, 45, 53) . Based on the ability of Sym1 to form a complex under similar conditions, we hypothesized that the 100-kDa complex shown in Fig. 4E To analyze which regions of Sym1 were necessary for import and assembly, we used truncation constructs with increasing Nand C-terminal deletions (Fig. 3D) . Sym1 constructs were imported into mitochondria, and the assemblies were monitored by BN-PAGE analyses after treatment of the samples with proteinase K (Fig. 4F) . Truncations at the N or C terminus, even those that eliminated one transmembrane segment from the N terminus or the C terminus, were still efficiently imported and protected against protease, indicating that neither the N nor the C terminus was necessary for the import of Sym1. However, constructs lacking one transmembrane segment did not assemble into mature complexes and remained in a monomeric form. N-terminal truncations exceeding one transmembrane domain displayed decreased amounts of monomers, indicative of reduced import efficiencies or increased turnover rates.
Sym1 forms an assembly intermediate in the TOM complex. The transient formation of the 450-kDa assembly intermediate suggested the formation of a complex of Sym1 with the TOM complex. Therefore, we omitted proteinase K treatment after import of Sym1 into mitochondria and monitored the assembly of the ADP/ATP carrier (AAC) as a control (Fig. 5A) . During BN-PAGE, the 450-kDa intermediate clearly accumulated after short import times when protease treatment was omitted ( Fig. 5A ; compare to Fig. 4E ). To investigate a potential interaction of Sym1 with the TOM complex, we compared the accessibility of the 450-kDa intermediate to externally added protease during optimized import times between 0.5 min and 6 min. As shown in Fig. 5B , at import times between 2 and 6 min, increasing amounts of precursor forming the 450-kDa intermediate were progressing into a ZZ isolated from mitochondria by IgG chromatography was analyzed by BN-PAGE and stained with Coomassie brilliant blue; (C) mitochondria were solubilized in digitonin-containing buffer, and complexes were separated by 1st-dimension BN-PAGE and 2nd-dimension SDS-PAGE and analyzed by Western blotting with the anti-Sym1 antibody; (D) mitochondria were solubilized in buffers containing digitonin (Dig.) or dodecyl maltoside (DDM), and the complexes were separated by 1st-dimension BN-PAGE and 2nd-dimension SDS gel and analyzed by Western blotting; (E) Sym1 import was monitored with BN-PAGE and subsequent digital autoradiography; (F) import and BN-PAGE analysis of truncation constructs described for Fig. 3D . Complexes were visualized by digital autoradiography. state where they were protected from protease. After 6 min of import, the 450-kDa intermediate strongly accumulated upon dissipation of the membrane potential. Protease treatment revealed that both protease-accessible and -nonaccessible forms were increased. We used these conditions in the following experiments to analyze our hypothesis that the 450-kDa complex represents an intermediate of Sym1 associated with the TOM complex.
In order to show an interaction of the imported precursor with the TOM complex, we performed antibody shift assays. After the import of Sym1, mitochondria were reisolated, solubilized, and incubated with antisera directed against Sym1, the central TOM subunits Tom22, Tom20, Tom5, and Tom40, and the peripheral TOM component Tom70. Binding of antibodies against Sym1 to the assembled [ 35 S]Sym1 dramatically affected the migration of complexes on BN-PAGE, whereas preimmune serum had no effect (Fig. 5C, lanes 1 and 7) . Antibodies against the central TOM components strongly affected the migration of a substantial fraction of the 450-kDa intermediate, indicating that the 450-kDa Sym1-containing complex represented an import intermediate of Sym1 associated with the TOM complex (Fig. 5C) . However, the peripheral TOM component Tom70 largely dissociated from the TOM complex upon solubilization with digitonin; therefore, no shift was observed with Tom70 antiserum. The low-molecularmass complexes were shifted only by Sym1 antiserum, indicating that these intermediates were detached from the tested Tom components.
In a complementary approach, we performed a depletion assay His -containing complexes were eliminated by incubation with Ni-NTA beads. Total (T) and unbound (U) fractions were separated by BN-PAGE and analyzed by digital autoradiography. using mitochondria from a yeast strain expressing the central TOM component Tom22 with a 10-histidine extension (tom22 His ) (38, 57) .
Sym1 was imported into Tom22
His -containing mitochondria. Solubilized mitochondrial extracts were then incubated with Ni-NTA agarose to remove Tom22
His and associated proteins from the extract. Binding of Tom22 to the resin efficiently depleted the 450-kDa intermediate (Fig. 5D) . Neither the 100-kDa intermediate nor the mature complexes were affected by the treatment. We conclude that the 450-kDa intermediate represents an intermediate stage of Sym1 import, in which the precursor is bound to the TOM complex and is partially accessible to protease treatment from the cytosolic side of the outer membrane.
Sym1 is transported independently of the TIM22 translocase. Precursor proteins are transported on different pathways from the TOM complex into the inner membrane. Considering that the N terminus of Sym1 was not required for import or assembly, Sym1 displayed channel activity, a stage III-like TOM intermediate was formed in the absence of a ⌬, and four predicted transmembrane domains were present, we speculate that Sym1, like Tim22 and Tim23, follows the carrier pathway for import (23, 24) . After translocation across the TOM complex, carrier precursors typically bind to the small TIM complex (Tim9/ Tim10), leading to stage III formation. Concomitantly, in the absence of a functional Tim9/Tim10 complex, carriers accumulate in the TOM complex in a protease-sensitive manner (6, 7, 26, 27, 44, 67) . In order to investigate an involvement of small TIM proteins in the transport of Sym1, we performed import and assembly assays in mutant mitochondria.
Temperature-conditional tim10-2 mitochondria were isolated from cells grown under permissive conditions and shifted to nonpermissive conditions prior to import (67) . While the ADP/ATP carrier, a typical substrate of the carrier pathway, displayed a strong decrease in these mutant mitochondria (Fig. 6A) , Sym1 assembly was not affected. This surprising result indicated that the Tim9/Tim10 complex was not involved in the transport of Sym1.
Proteins transported via the carrier pathway are integrated into the inner membrane via the TIM22 complex. To investigate involvement of the carrier translocase in the insertion of Sym1 into the inner membrane, we used mitochondria isolated from temperature-conditional mutant strains. The temperature-sensitive allele tim54-11 impairs the function of the core constituent Tim54 (24, 28, 71) . Tim12 is an essential constituent of the carrier translocase exposed to the intermembrane space (1, 17, 26, 59 ). The temperature-sensitive tim12-4 mutant displayed a strongly reduced efficiency of carrier import compared to the wild type (17) . Mitochondria isolated from cells grown under permissive temperature conditions were shifted to the restrictive temperature prior to import. While AAC import and assembly were severely affected in both mitochondria mutants compared to in the wild-type control, Sym1 assemblies in the mutant mitochondria were similar to those in the wild-type mitochondria ( Fig. 6B and C) . In summary, these data demonstrate that neither the TIM22 complex nor the small TIM complex was required for Sym1 import and assembly into the inner membrane. We conclude that despite the lack of a cleavable N-terminal presequence, Sym1 is not imported via the carrier pathway.
Import and assembly of Sym1 require the presequence translocase. Presequence-containing proteins are imported by the presequence translocase (TIM23 complex). Since the carrier translocase (TIM22 complex) was not involved in the transport and integration of Sym1, we assessed if Sym1 was transported by the TIM23 complex despite the absence of a cleavable presequence. Therefore, we used a yeast strain in which the channel-forming component of the presequence translocase, Tim23, was expressed under the control of a galactose-inducible promoter. Growth of Radiolabeled proteins were imported into mitochondria isolated from the WT and the tim10-2 (A), tim54-11 (B) and tim12-4 (C) mutant strains. In vitro import was performed for the indicated times in the presence or absence of a membrane potential (⌬). Reisolated mitochondria were solubilized in digitonin and analyzed by BN-PAGE and digital autoradiography.
yeast cells in the presence of glucose decreases the expression of Tim23 and allows the isolation of mitochondria with significantly reduced Tim23 levels (56) . When Sym1 was imported into mitochondria with reduced levels of Tim23, assembly was strongly affected (Fig. 7A) . Compared to that of wild-type mitochondria, assembly of Sym1 c120 was strongly delayed, and Sym1 c220 was almost not detectable. Instead, Sym1 IMS and monomeric Sym1 accumulated independently of the presence or absence of a ⌬. Moreover, the 450-kDa TOM complex intermediate was prominent in Tim23 shut-down mitochondria over the course of the assay (Fig. 7A) . These data suggest that the presequence translocase plays a role in the transport of Sym1 and that, under conditions in which the amount of Tim23 becomes limiting, transport intermediates of Sym1 accumulate. In contrast, assembly of AAC was not significantly affected in the mutant mitochondria. However, due to a loss of membrane potential in the absence of a functional translocase, the stage III intermediate was more prominent in the mutant mitochondria at early time points.
To exclude indirect effects, such as reduced ⌬, we imported Sym1 into mitochondria purified from a temperature-conditional strain carrying mutations in the import receptor Tim50. Tim50 is a central component of the presequence translocase that regulates Tim23 channel activity and is required for transport along the presequence pathway. In tim50-1 mutant cells, Tim50 function is impaired after a shift to nonpermissive temperature conditions, leading to selective defects in the transport of presequence-containing proteins through the TIM23 complex (5). Compared to wild-type mitochondria, tim50-1 mutant mitochondria displayed apparent defects in Sym1 assembly and an accumulation of Sym1 monomers (Fig. 7B, lanes 1 and 5) . Quantification of the amounts of assembled Sym1 in the 120-kDa and 220-kDa complexes revealed drastically slower kinetics in the tim50-1 mutant (Fig. 7E) , indicating that Tim50 is required for efficient assembly. In contrast to Sym1, import and assembly of AAC were comparable to those of the wild-type version (Fig. 7B) , as reported previously (5, 56) . The finding that the TIM23 complex was required for Sym1 biogenesis, as indicated by the defect in tim50-1 mitochondria, led us to investigate if the presequence receptor function of Tim50 was required for import or assembly. Therefore, we used mitochondria from a strain expressing TIM50 under the control of a galactose-inducible promoter from the chromosomal locus. This strain allows the selective reduction of Tim50 levels. We expressed a wild-type version of Tim50 (Tim50 HA ) or a version of Tim50 (Tim50 ⌬PBD-HA ) lacking the essential presequence-binding do- main in this background (56) . The rates of import of the presequence-containing precursor F 1 ␤ or the model matrix protein Su9-DHFR into the mutant mitochondria were reduced to 20% and 25%, respectively, after 16 min of import (Fig. 7C ). In contrast, import and assembly of Sym1 and AAC were not affected ( Fig. 7D and F) . Altogether, these experiments showed that Sym1 is directed to the presequence translocase, where it is transported in a Tim50-and Tim23-dependent manner. However, in contrast to the drastic kinetic delay of Sym1 import in tim50-1 mutants, the assembly into the Tim50 ⌬PBD-HA mutant was comparable to that of the wild-type (Fig. 7E and F) , indicating that the import reaction bypasses the requirement for presequence recognition at the translocase by the receptor Tim50. Thus, we conclude that the TIM23 complex is able to transport substrates, such as Sym1, that lack an N-terminal presequence segment, indicating a presequence-independent mode of action for this translocase.
DISCUSSION
Mutations in human MPV17 lead to the hepatocerebral form of mitochondrial DNA depletion syndrome (MDDS) (62) . Seven of eight genes that have been linked to MDDS were found to play a direct role in mitochondrial DNA maintenance (13, 19, 41, 54, 62) . The depletion of the mitochondrial DNA phenotype and the concomitant decrease of respiratory activity were recapitulated in MPV17 knockout mice. However, the function of MPV17 is still enigmatic. In this study we have demonstrated that Sym1, the orthologue of MPV17, forms a channel in the inner mitochondrial membrane. The conductance (G) of ϳ450 pS corresponds to a pore size of about 1.6 nm (60), sufficient to allow the transport of large molecules such as metabolites across the inner mitochondrial membrane. However, the physiological function of the channel and the nature of the cargo remain unknown. Similar to the Tim23 and Tim22 channels of the inner membrane, Sym1 closure occurs toward the physiological membrane potential, indicating a means to prevent ion leakage. It is likely that specific factors exist in vivo that regulate channel gating.
As suggested for the channel-forming inner membrane proteins Tim22 and Tim23, four transmembrane domains do not suffice for pore formation (50, 66) . In the case of Sym1, we were able to detect two complexes of 120 and 220 kDa. These findings agree with those of a previous study that indicated the presence of Sym1 in a high-molecular-mass complex (8) . As we used denaturing conditions to purify Sym1 for our electrophysiological measurements, it remains to be analyzed if unknown constituents of the detected complexes might modulate the observed channel properties. It is also unclear if both complexes are functionally relevant, if they play different physiological roles within the membrane, and if further components are involved in complex formation.
The observed channel activity of Sym1 raised questions on its import and integration into the inner membrane. Two major import pathways direct nucleus-encoded proteins into the inner mitochondrial membrane. Presequence-containing proteins are transported by the presequence translocase (TIM23), which not only mediates full matrix translocation but also integrates proteins into the inner membrane (5, 15, 18, 29, 39, 68, 70) . In contrast, metabolite carriers and the channel proteins Tim22 and Tim23 are directed into mitochondria by internal signals and use the TIM22 translocase for membrane integration. In silico analyses have suggested significant presequence probabilities for MPV17 and Sym1. However, we did not observe processing of the proteins after import into yeast or human mitochondria. Moreover, removal of N-or C-terminal segments of Sym1 did not block import of the precursor proteins, excluding an essential role of these regions for the transport process. We therefore conclude that internal targeting sequences are involved in Sym1 transport.
Analysis of Sym1 import into isolated mitochondria revealed intermediates in the transport process. A complex of 450 kDa represents an outer membrane transport intermediate in the TOM complex. A productive intermediate of a TIM23 substrate with the TOM complex has been shown for the multispanning protein OxaI, which utilizes an N-terminal presequence (16) . This intermediate was identified in the absence of a membrane potential and remained accessible to external proteases, indicating that OxaI did not fully pass the TOM complex at this stage and required the membrane potential to be further translocated across the outer membrane (5, 16) . Sym1 TOM intermediates were identified in energized mitochondria and remained fully accessible to protease only at early stages of import. At later stages, an increasing fraction was protected from externally added protease. This indicates that the intermediate of 450 kDa represents more than one distinct import stage. This behavior was reminiscent of that of substrates of the carrier pathway that form protease-resistant stage III intermediates in the TOM complex in the absence of a membrane potential.
The small Tim proteins of the intermembrane space typically transport multispanning proteins with internal targeting sequences to the carrier translocase (6, 27, 59) . Our analyses showed that neither the small Tim protein complex (Tim9/ Tim10) nor the essential TIM22 complex constituents Tim12 and Tim54 are required for import and assembly of Sym1. Instead, we have demonstrated that the presequence translocase is required for inner membrane transport of Sym1. Import and assembly of Sym1 were strongly affected by depletion of the Tim23 channel and by the inactivation of Tim50. These data reveal an involvement of the presequence translocase in the transport of proteins with internal targeting signals. A small number of TIM23 substrates have been identified that lack an amino-terminal cleavable presequence. This holds true for Pam18, Mdj2, and Bcs1, which span the inner membrane with a single transmembrane segment (14, 39, 73) . The current view is that presequence-like elements adjacent to the single membrane span direct these precursors to the TIM23 complex (40) . In the case of the soluble helicase Hmi1, a cleavable C-terminal presequence is used for transport along the presequence pathway (33) . In Sym1, neither terminus is essential for import, indicating the presence of internal targeting information. Moreover, in our in silico analyses, we did not detect internal segments adjacent to transmembrane spans with high presequence probability in Sym1. To experimentally assess if presequence-like elements of Sym1 are required for transport by the presequence translocase, we utilized a mutant of Tim50 which lacked the presequence-binding domain (56) . While the import of classical presequence-containing precursors was blocked in these mitochondria, the import of Sym1 was not affected. Hence, our analyses revealed that the presequence translocase is able to transport a protein substrate with internal targeting signals in a presequence-independent manner (Fig. 8) . Future work will have to clarify which segments in the Sym1 precursor are recognized by the TIM23 complex in order to promote membrane insertion.
